19
Avet Pharmaceuticals, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is DOXYCYCLINE HYCLATE, with a corresponding application number 200856.
Regulatory Information RX
With a dosage strength EQ 200MG BASE
Dosage Form Route TABLET, DELAYED RELEASE; ORAL
Reference Listed Drug No
Approved since 2018-11-13
Therapeutic Equivalence (TE) Code AB
18
Avet Pharmaceuticals, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is DOXYCYCLINE HYCLATE, with a corresponding application number 200856.
Regulatory Information RX
With a dosage strength EQ 100MG BASE
Dosage Form Route TABLET, DELAYED RELEASE; ORAL
Reference Listed Drug No
Approved since 2013-04-30
Therapeutic Equivalence (TE) Code AB
17
Avet Pharmaceuticals, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is DOXYCYCLINE HYCLATE, with a corresponding application number 200856.
Regulatory Information RX
With a dosage strength EQ 150MG BASE
Dosage Form Route TABLET, DELAYED RELEASE; ORAL
Reference Listed Drug No
Approved since 2013-04-30
Therapeutic Equivalence (TE) Code AB
16
Avet Pharmaceuticals, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is DOXYCYCLINE HYCLATE, with a corresponding application number 200856.
Regulatory Information RX
With a dosage strength EQ 75MG BASE
Dosage Form Route TABLET, DELAYED RELEASE; ORAL
Reference Listed Drug No
Approved since 2013-04-30
Therapeutic Equivalence (TE) Code AB